المؤلفون: Scheen, André, Moutschen, Michel

المصدر: Revue Médicale de Liège, 75 (S1), 162-169 (2020)

مصطلحات موضوعية: Antiviral Agents/therapeutic use, Betacoronavirus, Coronavirus Infections/drug therapy, Humans, Pandemics, Pneumonia, Viral, Clinical research, Hydroxychloroquine, Immunomodulation, SARS-CoV-2, Antiviral agents, Human health sciences, Pharmacy, pharmacology & toxicology, Immunology & infectious disease, Sciences de la santé humaine, Pharmacie, pharmacologie & toxicologie, Immunologie & maladie infectieuse

Relation: urn:issn:0370-629X; urn:issn:2566-1566

URL الوصول: https://orbi.uliege.be/handle/2268/254643

المؤلفون: Zhuoer Xie, Julie T Wu, Huili Zhu, Deborah B. Doroshow, Yu Shyr, Thorvardur R. Halfdanarson, Jessica Hawley, Sanjay Mishra, Lidia Schapira, Leslie A. Fecher, Sanjay Goel, Samuel M. Rubinstein, Petros Grivas, Pamela C Egan, Solange Peters, Sumit A. Shah, Gary K. Schwartz, Michael A. Thompson, Jonathan T Arcobello, Chih-Yuan Hsu, Christopher R. Friese, Dimitrios Farmakiotis, Corrie A. Painter, Matthew D. Galsky, Nicole M. Kuderer, Nathan A. Pennell, Ziad Bakouny, Sanjay G. Revankar, Brian I. Rini, Albert C. Yeh, Donna R. Rivera, Jeremy L. Warner, Dimpy P. Shah, Brendan J Lee, Ali Raza Khaki, Adam J. Olszewski, Matthew Puc, Orestis A. Panagiotou, Gary H. Lyman, Christopher Lemmon, Balazs Halmos, Andrew Schmidt, Toni K. Choueiri, Gilberto Lopes, Shilpa Gupta

المساهمون: COVID-19 and Cancer Consortium

المصدر: Cancer Discovery
Cancer discovery, vol. 10, no. 10, pp. 1514-1527

مصطلحات موضوعية: Male, 0301 basic medicine, Logistic regression, Severity of Illness Index, 0302 clinical medicine, Risk Factors, Neoplasms, Hospital Mortality, Research Articles, Alanine, Age Factors, Middle Aged, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Coronavirus Infections, Hydroxychloroquine, Cohort study, medicine.drug, medicine.medical_specialty, Clinical Decision-Making, Pneumonia, Viral, Betacoronavirus, 03 medical and health sciences, Sex Factors, Pharmacotherapy, Internal medicine, Statistical significance, Severity of illness, medicine, Humans, Healthcare Disparities, Glucocorticoids, Pandemics, Aged, Adenosine Monophosphate/analogs & derivatives, Adenosine Monophosphate/therapeutic use, Alanine/analogs & derivatives, Alanine/therapeutic use, Betacoronavirus/pathogenicity, Coronavirus Infections/complications, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Coronavirus Infections/mortality, Drug Therapy, Combination/methods, Drug Therapy, Combination/statistics & numerical data, Drug Utilization/statistics & numerical data, Follow-Up Studies, Glucocorticoids/therapeutic use, Healthcare Disparities/statistics & numerical data, Hydroxychloroquine/therapeutic use, Neoplasms/complications, Neoplasms/mortality, Pneumonia, Viral/complications, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Pneumonia, Viral/mortality, United States/epidemiology, SARS-CoV-2, business.industry, COVID-19, Cancer, medicine.disease, Adenosine Monophosphate, Drug Utilization, United States, COVID-19 Drug Treatment, 030104 developmental biology, Observational study, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19be86f094f92aafe7221786c1b2cd6
https://doi.org/10.1158/2159-8290.cd-20-0941

المؤلفون: Susara Blunden, Alexander Mentzer, Tom Dymond, Robert Heyderman, Stacy Todd, Richard Haynes, Ahmad Abu-Arafeh, William Ricketts, Simon Drysdale, Danyal Jajbhay, Grant D. Stewart, Andrew Ustianowski, Jane Blazeby, Ashton Barnett-Vanes, Nicholas Kametas, Elizabeth Bancroft, Ankur Gupta-Wright, Hanif Esmail, Gerard McKnight, Catherine Harwood, Joe Fawke, Vivien Price, Tuck-Kay Loke, Kieran Nunn, Mili Estee Torok, Wei Shen Lim, Vishal Dey, Brendan Payne, Alexander Stockdale, Charles Christoph Roehr, Dominic Crocombe, Imogen Skene, Martin Landray, Anna Bibby, Jamie Brannigan, Padmasayee Papineni, Søren Kudsk-Iversen, Kathryn Puxty, Katrina Cathie, Maheshi Nirmala Ramasamy, Alan Montgomery, Louis Grandjean, Xin Hui Chan, Ben Gibbison, Cielito Caneja, Dinesh Saralaya, Omer Elneima, Charles Reynard, Natalie Blencowe, Eleanor Mishra, Henry HL Wu, Roy Soiza, Patrick Lillie, Paul Pfeffer, Christian Alexander Linares, Simon Tso, Benjamin Caplin, Sarah Burge, Sakib Rokadiya, Brunskill Nigel, Joel Tarning, Manish Patel, Jamie Cooper, Lee Hoggett, Nazima Pathan, Alex Horsley, Saul Faust, Martin Llewelyn, Alex Scott, Kim Hinshaw, Giorgio Calisti, Effrossyni Gkrania-Klotsas, Shaman Jhanji, Ben Burton, Anna Daunt, Chetan Parmar, Chris Imray, Christopher Green, Jonathan Underwood, Mark Peters, James A Watson, Eoin O'Sullivan, Pallav Shah, Paul Dark, Luke Hodgson, Ryan Malcolm Hum, Varun Sarodaya, Pilar Rivera Ortega, Jonathan Emberson, Ben Shelley, Richard Adams, Joseph Barker, John Kenneth Baillie, Manu Vatish, Tony Whitehouse

المساهمون: University of St Andrews. School of Medicine, Group, RECOVERY Collaborative, Jaki, Thomas [0000-0002-1096-188X], Apollo - University of Cambridge Repository

المصدر: NEW ENGLAND JOURNAL OF MEDICINE
RECOVERY Collaborative Group & Evans, D G 2020, ' Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 ', The New England Journal of Medicine, vol. 383, no. 21, pp. 2030-2040 . https://doi.org/10.1056/NEJMoa2022926, https://doi.org/10.1056/nejmoa2022926
The New England journal of medicine, vol. 383, no. 21, pp. 2030-2040, 2020.
The New England Journal of Medicine

مصطلحات موضوعية: Male, medicine.medical_treatment, 030204 cardiovascular system & hematology, Rate ratio, law.invention, Pneumonia, viral/drug therapy, chloroquine, 0302 clinical medicine, Randomized controlled trial, law, RA0421, RA0421 Public health. Hygiene. Preventive Medicine, klorokin, 030212 general & internal medicine, Treatment Failure, Middle aged, Coronavirus infections/drug therapy, Aged, 80 and over, Incidence (epidemiology), General Medicine, 3rd-DAS, Middle Aged, hidroksiklorokin, Antiviral Agents/adverse effects, Covid-19 -- drug therapy, Hospitalization, Doxycycline, Hydroxychloroquine/adverse effects, Original Article, Female, Coronavirus Infections, covid-19 -- terapija z zdravili, medicine.drug, Hydroxychloroquine, medicine.medical_specialty, RM, hydroxychloroquine, Pneumonia, Viral, Antiviral Agents, 03 medical and health sciences, Betacoronavirus, SDG 3 - Good Health and Well-being, Internal medicine, udc:616.9, medicine, Humans, Pandemics, Aged, Mechanical ventilation, business.industry, SARS-CoV-2, COVID-19, NIS, Interim analysis, Respiration, Artificial, Confidence interval, RM Therapeutics. Pharmacology, COVID-19 Drug Treatment, Treatment failure, Relative risk, Respiration, artificial, business

وصف الملف: application/pdf; text/url

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3508cd0098c2966729f1cf3555643f26
https://pubmed.ncbi.nlm.nih.gov/35232857

المؤلفون: Fernando G. Zampieri

المصدر: Annals of the American Thoracic Society
Zampieri, F G 2020, ' Deploying randomized controlled trials during the COVID-19 pandemic : Reason and bayesian designs ', Annals of the American Thoracic Society, vol. 17, no. 8, pp. 937-938 . https://doi.org/10.1513/ANNALSATS.202005-463ED

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, 2019-20 coronavirus outbreak, hydroxychloroquine, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Bayesian probability, Pneumonia, Viral, Azithromycin, law.invention, Bayes' theorem, Betacoronavirus, Randomized controlled trial, law, Pandemic, Medicine, Humans, Pandemics, Randomized Controlled Trials as Topic, Clinical Study Design, business.industry, SARS-CoV-2, COVID-19, Bayes Theorem, clinical trial, Coronavirus Infections/drug therapy, COVID-19 Drug Treatment, Risk analysis (engineering), business, Coronavirus Infections, Hydroxychloroquine

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e97a65a190cd608870cb77ebce00c2c3
https://pubmed.ncbi.nlm.nih.gov/32425051

المؤلفون: Michel Obeid, Alfredo Addeo, Alex Friedlaender

المصدر: Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol. 8, no. 1, pp. e000892

مصطلحات موضوعية: 0301 basic medicine, ARDS, Cancer Research, Lung Neoplasms, T-Lymphocytes, Pneumonia, Viral, Immunology, Lung injury, Antibodies, Monoclonal, Humanized, Antiviral Agents, Proinflammatory cytokine, 03 medical and health sciences, chemistry.chemical_compound, Betacoronavirus, 0302 clinical medicine, Tocilizumab, Risk Factors, Intensive care, Neoplasms, medicine, Humans, Immunology and Allergy, Lung cancer, Lung, Pandemics, Pneumonitis, Pharmacology, Clinical Trials as Topic, business.industry, Interleukin-6, SARS-CoV-2, COVID-19, medicine.disease, immunity, Cytokine release syndrome, 030104 developmental biology, Antibodies, Monoclonal, Humanized/therapeutic use, Antiviral Agents/therapeutic use, Coronavirus Infections/drug therapy, Coronavirus Infections/etiology, Coronavirus Infections/prevention & control, Hydroxychloroquine/therapeutic use, Interleukin-6/metabolism, Lung/pathology, Lung Neoplasms/complications, Lung Neoplasms/drug therapy, Lung Neoplasms/virology, Neoplasms/virology, Pandemics/prevention & control, Pneumonia, Viral/drug therapy, Pneumonia, Viral/etiology, Pneumonia, Viral/prevention & control, lung neoplasms, chemistry, Oncology, 030220 oncology & carcinogenesis, Commentary, Molecular Medicine, business, Coronavirus Infections, Hydroxychloroquine

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0877762bcab70475a2c9d0e0e76bb6

المؤلفون: Emília C. Monteiro, Natalia Marto

المصدر: Acta Médica Portuguesa, Vol 33, Iss 7-8, Pp 500-504 (2020)

مصطلحات موضوعية: Pneumonia, Viral, coronavirus, lcsh:Medicine, medicine.disease_cause, Antibodies, Monoclonal, Humanized, Global Health, Antiviral Agents, Lopinavir, covid-19/drug therapy, Betacoronavirus, coronavirus infections/drug therapy, medicine, Humans, Pandemics, Coronavirus, lcsh:R5-920, Alanine, Ritonavir, business.industry, SARS-CoV-2, lcsh:R, COVID-19, Chloroquine, General Medicine, Drugs, Investigational, Off-Label Use, Virology, Adenosine Monophosphate, Drug Combinations, business, lcsh:Medicine (General), Coronavirus Infections, Hydroxychloroquine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21475c56d7280bf564e65f02b65ef5a4
https://pubmed.ncbi.nlm.nih.gov/32425152

المؤلفون: Elena Sumarokova, Gina Gualano, Evgeny Belilovski, Armine Izadifar, Eva Tabernero, Pierre Bachez, Alessandro Torre, Maria Luiza de Souza-Galvão, François-Xavier Blanc, Claire Andrejak, Mathilde Fréchet Jachym, Denise Rossato Silva, Paolo Scarpellini, Margarita Marín Royo, Dina Visca, Ángel Domínguez-Castellano, Teresa Rodrigo, Antoine Froissart, Damien Le Dû, Giovanni Sotgiu, Antonio Spanevello, Pierre-Alexandre Bart, Simon Tiberi, Miguel Zabaleta Murguiondo, Frédéric Schlemmer, Marina Tadolini, Rosella Centis, Matteo Saporiti, Sergey Borisov, Giovanni Battista Migliori, Vania Giacomet, Delia Goletti, Frédéric Rivière, Ilaria Motta, Samir Dourmane, Soazic Grard, José Cardoso-Landivar, José-María García-García, Jesica Mazza-Stalder, Fabrizio Palmieri, Luigi Codecasa, Catherine W.M. Ong, Adrián Sánchez-Montalvá, Lia D'Ambrosio, Jan-Willem C. Alffenaar, Paul A. Tambyah

المساهمون: Tadolini M., Codecasa L.R., Garcia-Garcia J.-M., Blanc F.-X., Borisov S., Alffenaar J.-W., Andrejak C., Bachez P., Bart P.-A., Belilovski E., Cardoso-Landivar J., Centis R., D'Ambrosio L., De Souza-Galvao M.-L., Dominguez-Castellano A., Dourmane S., Jachym M.F., Froissart A., Giacomet V., Goletti D., Grard S., Gualano G., Izadifar A., Le Du D., Royo M.M., Mazza-Stalder J., Motta I., Min Ong C.W., Palmieri F., Riviere F., Rodrigo T., Silva D.R., Sanchez-Montalva A., Saporiti M., Scarpellini P., Schlemmer F., Spanevello A., Sumarokova E., Tabernero E., Tambyah P.A., Tiberi S., Torre A., Visca D., Murguiondo M.Z., Sotgiu G., Migliori G.B., Centre hospitalier universitaire de Nantes (CHU Nantes), University Medical Center Groningen [Groningen] (UMCG), CHU Amiens-Picardie, Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, CHU Henri Mondor, Centre Hospitalier Intercommunal de Créteil (CHIC), Istituto Nazionale di Malattie Infettive 'Lazzaro Spallanzani' (INMI), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Hôpital Raymond Poincaré [AP-HP], Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Maturation des proteines, destinée cellulaire et thérapeutique (PROMTI), Département Biologie des Génomes (DBG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Aristotle University of Thessaloniki, [Tadolini,m] Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. [Codecasa,LR, Saporiti,M] TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy. [García-García,JM, Rodrigo,T]Tuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain. [Blanc,FX] Centre Hospitalier Universitaire, Nantes, France. [Borisov,S, Belilovski,E, Sumarokova,E] Moscow Research and Clinical Center for TB Control, Moscow, Russian Federation. [Alffenaar,JW] The University of Sydney, Sydney Pharmacy School, Sydney, Australia. [Alffenaar,JW] Westmead Hospital, Sydney, Australia. [Alffenaar,JW] Marie Bashir Institute of Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia. [Andréjak,C] Service de Pneumologie CHU AMIENS PICARDIE, France AND UR Université de Picardie Jules Verne, Amiens, France. [Bachez,P] Service de Pneumologie, Clinique Saint Luc, Bouge, Belgium. [Bart,PA] Dept of Internal Medicine, Lausanne University, Lausanne, Switzerland. [Cardoso-Landivar,J] Servicio Neumología, Vall D´Hebron University Hospital, Barcelona, Spain. [Centis,R] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy. [D'Ambrosio,L] Public Health Consulting Group, Lugano, Switzerland. [Dominguez-Castellano,A] Servicio de Enfermedades Infecciosas y Microbiología, Hospital Virgen Macarena, Sevilla, Spain. [Dourmane,S] Service de Pneumologie, Groupe hospitalier sud île de France (GHSIF), Melun, France. [Fréchet Jachym,M, Le Du,D] Centre Hospitalier de Bligny, Briis Sous Forges, France. [Froissart,A] Service de Médecine interne, CHI de Créteil, Créteil, France. [Giacomet,V]20Pediatric Infectious Diseases Unit, Dept of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy. [Goletti,D] Translational Research Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Grard,S] Centre de Lutte Antituberculeuse (CLAT 38), Grenoble, France. [Gualano,G, Palmieri,F] Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy. [Izadifar,A] Hôpital Européen de Paris La Roseraie, Aubervilliers, France. [Marín Royo,M] Servicio Neumología, Hospital General Universitario de Castellón, Castelló, Spain. [Mazza-Stalder,J] Pulmonary Division, Lausanne University Hospital CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. [Motta,I] Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italia. [Ong,CWM, Tambyah,PA] Dept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [Ong,CWM, Tambyah,PA] Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore. [Rivière,F] Hôpital d'Instruction des Armées (HIA) Percy, Clamart, France. [Silva,DR] Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS, Porto Alegre, Brazil. [Sánchez-Montalvá,A]Infectious Diseases Dept, International Health and Tuberculosis Unit, Vall d'Hebron University Hospital, Barcelona, Spain. [Sánchez-Montalvá,A] Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain. [Sánchez-Montalvá,A] Grupo de Estudio de Infecciones por Micobacterias (GEIM), Spanish Society of Infectious Diseases (SEIMC), Spain. [Scarpellini,P] Unit of Infectious Diseases, Università Vita e Salute, San Raffaele Hospital, Milan, Italy. [Schlemmer,F] Hôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France. [Spanevello,A, Visca,D] Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy. [Spanevello,A, Visca,D] Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Tradate, Italy. [Tabernero,E] Servicio Neumología, Hospital de Cruces, Bilbao, Spain. [Tiberi,S] Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. [Tiberi,S] Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. [Torre,A] Dept of Infectious Diseases, University of Milan, L. Sacco Hospital, Milan, Italy. [Zabaleta Murguiondo,M] Servicio Neumología Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Sotgiu,G] Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. [Migliori,GB] Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy., CHU Henri Mondor [Créteil]

المصدر: The European Respiratory Journal
article-version (AM) Accepted Manuscript
The European respiratory journal, vol. 56, no. 1
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩
European Respiratory Journal, 2020, 56 (1), ⟨10.1183/13993003.01398-2020⟩

مصطلحات موضوعية: Male, Pediatrics, Adult, Aged, Antitubercular Agents/therapeutic use, Antiviral Agents/therapeutic use, Azithromycin/therapeutic use, Betacoronavirus, Clinical Laboratory Techniques, Cohort Studies, Coinfection, Coronavirus Infections/complications, Coronavirus Infections/diagnosis, Coronavirus Infections/drug therapy, Drug Combinations, Emigrants and Immigrants, Female, Humans, Hydroxychloroquine/therapeutic use, Lopinavir/therapeutic use, Lung/diagnostic imaging, Middle Aged, Mortality, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/diagnosis, Pneumonia, Viral/drug therapy, Ritonavir/therapeutic use, Tomography, X-Ray Computed, Tuberculosis/complications, Tuberculosis/diagnosis, Tuberculosis/drug therapy, Tuberculosis, Pulmonary/complications, Tuberculosis, Pulmonary/diagnosis, Tuberculosis, Pulmonary/drug therapy, [SDV]Life Sciences [q-bio], viruses, Antitubercular Agents, Azithromycin, Clinical Laboratory Technique, Lopinavir, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Sequelae, Antitubercular Agent, 0302 clinical medicine, COVID-19 Testing, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography [Medical Subject Headings], Drug Combination, 030212 general & internal medicine, Viral, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques [Medical Subject Headings], Lung, Tomography, ComputingMilieux_MISCELLANEOUS, Health Care::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Vital Statistics::Mortality [Medical Subject Headings], virus diseases, Pulmonary, respiratory system, X-Ray Computed, Impactos en la salud, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography [Medical Subject Headings], Cohort, Coronavirus Infections, medicine.drug, Cohort study, Human, Hydroxychloroquine, Impacts on health, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Tuberculosis, Tuberculosi, Infecciones por coronavirus, Estudios de cohortes, Pneumonia, Viral, Antiviral Agents, Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Mycobacterium Infections::Tuberculosis [Medical Subject Headings], 03 medical and health sciences, Tuberculosis diagnosis, medicine, Research Letter, Tuberculosis, Pulmonary, Secuelas, Ritonavir, Antiviral Agent, Pandemia, Betacoronaviru, Pandemic, business.industry, Coronavirus Infection, SARS-CoV-2, COVID-19, Emigrants and Immigrant, Pneumonia, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents::Antitubercular Agents [Medical Subject Headings], medicine.disease, Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [Medical Subject Headings], COVID-19 Drug Treatment, Coronavirus, 030228 respiratory system, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Cohort Studie, business

وصف الملف: ELETTRONICO; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe58fdd4efa3f56b2737cc2d5e084a8
http://hdl.handle.net/11383/2095863

المؤلفون: Leandro Genehr Fritscher, José Miguel Chatkin, Sergio Cimerman, Maicon Falavigna, Mirian de Freitas Dal Ben Corradi, Michelle Silva Nunes, Jessica Yumi Matuoka, Rachel Riera, Flávia Cordeiro Medeiros, Haliton Alves de Oliveira Junior, Cinara Stein, Clovis Arns da Cunha, Gabriela Vilela de Brito, Lays Pires Marra, Marcelo Basso Gazzana, Felipe Dal-Pizzol, Regis Goulart Rosa, Cassia Garcia Moraes Pagano, Amilton Silva Júnior, Alexandre P. Zavascki, Bruno de Melo Tavares, Verônica Colpani, Patrícia do Carmo Silva Parreira, Angela Bagattini, Luciano Cesar Pontes Azevedo, Daniela Vianna Pachito, Débora Dalmas Gräf

المصدر: Revista Brasileira de Terapia Intensiva, Volume: 32, Issue: 2, Pages: 166-196, Published: 13 JUL 2020
Revista Brasileira de Terapia Intensiva

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Oseltamivir, Pneumonia, Viral, Context (language use), Guidelines, Critical Care and Intensive Care Medicine, Azithromycin, Special Article, Betacoronavirus, 03 medical and health sciences, chemistry.chemical_compound, Tocilizumab, Infecções por coronavirus/tratamento farmacológico, Internal medicine, medicine, Humans, Intensive care medicine, Pandemics, Coronavirus infections/drug therapy, 030505 public health, SARS-CoV-2, business.industry, Brasil, 030111 toxicology, COVID-19, Hydroxychloroquine, Diretrizes, General Medicine, Clinical trial, GRADE, Systematic review, Pulmonology, chemistry, Coronavirus Infections, 0305 other medical science, business, Brazil, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c30d7d75dbb1542b99568e733255353
https://doi.org/10.5935/0103-507x.20200039